Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | The Journal of Headache and Pain

Fig. 3

From: Inhibition of 2-AG hydrolysis alleviates posttraumatic headache attributed to mild traumatic brain injury

Fig. 3

Treatment with MJN110 inhibited the expression of calcitonin gene related peptides (CGRP) in TG and TNC of mTBI mice. On day 7 post-injury, the CGRP positive immunostaining increased in the TG and TNC of mTBI mice compared to the sham group and decreased by the MJN treatment (A, C). The number of positive CGRP cells in the TG of mTBI mice was significantly higher than that in the sham group and greatly reduced by MJN (B). The same phenomenon was observed in the TNC of mTBI mice (D). *, p < 0.05, and **, p < 0.01 were obtained when the MJN treatment group compared to the TBI/vehicle group (n = 10). The mRNA levels of the calcitonin-receptor like receptor (Clr) (E) and the receptor activity modifying protein 1 (Ramp1) (F) in the TG were also increased in the TBI/vehicle group and suppressed in the MJN treatment group (n = 12/group). Scale bar = 50 μm

Back to article page